We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
BIO-RAD LABORATORIES

Download Mobile App




Disrupted Molecular Signaling Drives Cancer Metastasis

By LabMedica International staff writers
Posted on 24 Jan 2017
Print article
Image: Molecular model of YAP (Yes-associated protein) (Photo courtesy of Wikimedia Commons).
Image: Molecular model of YAP (Yes-associated protein) (Photo courtesy of Wikimedia Commons).
A malfunction in molecular signaling that continually activates Yes-associated protein (YAP) has been linked to the ability of metastatic cancer cells to break away from the extracellular matrix (ECM) and travel throughout the body.

In order to study the interaction between YAP and ECM, investigators at The Institute of Cancer Research had to solve the technical challenge caused by perturbations that affect cell shape and, indirectly, protein localization. To this end they developed a method using single-cell image analysis and statistical models that exploited the naturally occurring heterogeneity of cellular populations.

The investigators then systematically deleted 950 individual genes in cancer cell lines to identify any that influenced YAP signaling. They reported in the January 5, 2017, online edition of the journal Cell Systems that the proteins beta-PIX and PAK2, were the drivers behind both YAP activation and cell-ECM adhesion turnover during cell spreading.

To examine how YAP's activity was controlled in cancer cells, the investigators worked with cultures of triple-negative breast cancer cells that were derived either from a primary tumor or from a metastatic site. They found that if the beta-PIX pathway was disabled in cells from the primary tumor, YAP failed to activate. In contrast, in cells taken from the site of metastasis, YAP did activate. This finding indicated that invasive cancer cells sustained high levels of YAP even when not bound to the surrounding matrix.

Senior author Dr. Chris Bakal, leader of the dynamical cell systems team at The Institute of Cancer Research, said, "Our research shows how cancer cells that have become invasive are able overcome the normal constraints on cell movement. Cancer cells that have spread around the body have a switch which is jammed on - allowing them to produce a molecule called YAP all the time. This allows them to keep growing and spreading throughout the body, ignoring the physical controls that would normally stop this happening. Understanding more about the physical processes which constrain and control the growth and movement of cells can open up exciting new avenues for cancer treatment, which may have been missed until now."

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
Xylazine Immunoassay Test
Xylazine ELISA

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Molecular Diagnostics

view channel
Image: A blood test could predict lung cancer risk more accurately and reduce the number of required scans (Photo courtesy of 123RF)

Blood Test Accurately Predicts Lung Cancer Risk and Reduces Need for Scans

Lung cancer is extremely hard to detect early due to the limitations of current screening technologies, which are costly, sometimes inaccurate, and less commonly endorsed by healthcare professionals compared... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: Exosomes can be a promising biomarker for cellular rejection after organ transplant (Photo courtesy of Nicolas Primola/Shutterstock)

Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies

Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more

Pathology

view channel
Image: Comparison of traditional histopathology imaging vs. PARS raw data (Photo courtesy of University of Waterloo)

AI-Powered Digital Imaging System to Revolutionize Cancer Diagnosis

The process of biopsy is important for confirming the presence of cancer. In the conventional histopathology technique, tissue is excised, sliced, stained, mounted on slides, and examined under a microscope... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.